Understanding Geospatial Factors Associated With Cervical Cancer Screening Uptake in Amazonian Peruvian Women.
Journal
JCO global oncology
ISSN: 2687-8941
Titre abrégé: JCO Glob Oncol
Pays: United States
ID NLM: 101760170
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
entrez:
7
8
2020
pubmed:
7
8
2020
medline:
29
7
2021
Statut:
ppublish
Résumé
Cervical cancer (CC) is the most common and second-most deadly cancer among Peruvian women. Access to services is strongly associated with CC screening uptake. This study investigated geospatial features contributing to utilization of screening. We used geolocated data and screening information from a Knowledge, Attitudes, and Practice (KAP) survey implemented in Iquitos, Peru in 2017. The KAP collected cross-sectional CC screening history from 619 female interviewees age 18-65 years within 5 communities of varying urbanization levels. We used spatial statistics to determine if screened households tended to cluster together or cluster around facilities offering screening in greater numbers than expected, given the underlying population density. On the basis of K-functions, screened households displayed greater clustering among each other as compared with clustering among unscreened households. Neighborhood-level factors, such as outreach, communication, or socioeconomic condition, may be functioning to generate pockets of screened households. Cross K-functions showed that screened households are generally located closer to health facilities than unscreened households. The significance of facility access is apparent and demonstrates that travel and time barriers to seeking health services must be addressed. This study highlights the importance of considering geospatial features when determining factors associated with CC screening uptake. Given the observed clustering of screened households, neighborhood-level dynamics should be further studied to understand how they may be influencing screening rates. In addition, results demonstrate that accessibility issues must be carefully considered when designing an effective cancer screening program that includes screening, follow-up, and treatment.
Identifiants
pubmed: 32755481
doi: 10.1200/GO.20.00096
pmc: PMC7456312
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1237-1247Subventions
Organisme : NCI NIH HHS
ID : R01 CA190366
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA190366
Pays : United States
Références
Cancer Nurs. 2019 Mar/Apr;42(2):106-118
pubmed: 29461283
JMIR Form Res. 2020 Mar 6;4(3):e14652
pubmed: 32032940
Salud Publica Mex. 2003;45 Suppl 3:S408-16
pubmed: 14746034
J Immigr Health. 2003 Jul;5(3):119-28
pubmed: 14512766
J Low Genit Tract Dis. 2015 Jul;19(3):229-33
pubmed: 25943865
J Immigr Minor Health. 2019 Jun;21(3):606-658
pubmed: 30117005
Rev Panam Salud Publica. 2009 Mar;25(3):189-95
pubmed: 19454145
J Adv Nurs. 2010 Feb;66(2):350-9
pubmed: 20423418
Aust N Z J Obstet Gynaecol. 2019 Apr;59(2):301-307
pubmed: 30614524
BMC Public Health. 2019 Jan 17;19(1):80
pubmed: 30654774
Matern Child Health J. 2008 Sep;12(5):624-32
pubmed: 17879148
Ann Fam Med. 2005 May-Jun;3(3):235-41
pubmed: 15928227
J Community Health. 2019 Jun;44(3):525-533
pubmed: 30915676
World J Clin Oncol. 2015 Dec 10;6(6):281-90
pubmed: 26677441
J Community Health. 2015 Dec;40(6):1047-56
pubmed: 25947012
Health Educ Res. 2008 Feb;23(1):10-24
pubmed: 17229778
Lancet Public Health. 2018 Sep;3(9):e438-e446
pubmed: 30143472
Int J Gynaecol Obstet. 2013 Aug;122(2):118-23
pubmed: 23731506
BMC Public Health. 2014 Jun 12;14:596
pubmed: 24927941
BMC Public Health. 2016 Feb 24;16:181
pubmed: 26911388
J Clin Epidemiol. 1990;43(1):87-91
pubmed: 2319285
Reprod Health Matters. 2012 Dec;20(40):49-58
pubmed: 23245408
J Rural Health. 2016 Spring;32(2):136-45
pubmed: 26265118
Cancer. 2007 Jan 15;109(2 Suppl):368-77
pubmed: 17173279
Prev Med. 2004 Jul;39(1):91-8
pubmed: 15207990
Rev Panam Salud Publica. 2013 Mar;33(3):174-82
pubmed: 23698136
Health Policy. 2004 May;68(2):223-32
pubmed: 15063021
Oncologist. 2013;18(12):1278-84
pubmed: 24217554
Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1373-8
pubmed: 19423518
Women Health. 2017 Nov-Dec;57(10):1161-1177
pubmed: 27700693
Int J Epidemiol. 2008 Aug;37(4):862-9
pubmed: 18653515
Asian Pac J Cancer Prev. 2011;12(7):1681-5
pubmed: 22126544
Int J Epidemiol. 1999 Feb;28(1):35-9
pubmed: 10195661
Gynecol Oncol. 2013 May;129(2):318-23
pubmed: 23385153
Am J Trop Med Hyg. 2015 Apr;92(4):857-864
pubmed: 25688165
Soc Sci Med. 2009 Mar;68(5):832-9
pubmed: 19152992
BMJ Glob Health. 2019 May 13;4(3):e001452
pubmed: 31179040
BMJ Glob Health. 2019 May 14;4(3):e001351
pubmed: 31179035
Am J Epidemiol. 1977 May;105(5):488-95
pubmed: 871121